Remdesivir, Hydroxychloroquine and COVID-19.
The article focuses on the hydroxychloroquine (HCQ ), a generic drug developed originally as a treatment for malaria. Topics include HCQ used in the treatment of COVID-19 disease; the use of HCQ for Covid in various countries has provided a quasi-experiment to assess its efficacy; and early use of H...
| Publicado en: | Quadrant Magazine Vol. 64; no. 11; pp. 22 - 28 |
|---|---|
| Autor principal: | |
| Formato: | Artículo |
| Publicado: |
Quadrant Magazine Co Inc.
Nov2020
|
| Materias: | |
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=hlh&AN=146760587&site=ehost-live header: @attributes: shortDbName: hlh uiTerm: 146760587 longDbName: Humanities International Complete uiTag: AN controlInfo: bkinfo: jinfo: jid: 00335002 QUA jtl: Quadrant Magazine issn: 00335002 maglogo: N pubinfo: dt: Nov2020 vid: 64 iid: 11 pid: 1578 pub: Quadrant Magazine Co Inc. artinfo: ui: 146760587 ppf: 22 ppct: 6 formats: fmt: @attributes: type: P size: 2.7MB tig: atl: Remdesivir, Hydroxychloroquine and COVID-19. aug: au: Kellow, Aynsley affil: Professor Emeritus of Government at the University of Tasmania. su: Hydroxychloroquine Generic drugs Malaria COVID-19 Death sug: subj: Hydroxychloroquine Generic drugs Malaria COVID-19 Death ab: The article focuses on the hydroxychloroquine (HCQ ), a generic drug developed originally as a treatment for malaria. Topics include HCQ used in the treatment of COVID-19 disease; the use of HCQ for Covid in various countries has provided a quasi-experiment to assess its efficacy; and early use of HCQ in COVID-19 disease show a 78 per cent reduction in deaths per million compared with those with limited early use. pubtype: Periodical doctype: Article src: R language: English refInfo: copyright: @attributes: flag: Y custom: Copyright of Quadrant Magazine is the property of Quadrant Magazine Co Inc. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. item: Quadrant Magazine holder: Quadrant Magazine Co Inc. dt: @attributes: year: 2020 holdings: @attributes: islocal: N |
|---|